Early research (Phase 1)Study completedNCT00073944What this trial is testingBCX-1777 in Treating Patients With Refractory CancerWho this might be right forCancer BioCryst Pharmaceuticals
Post-approval studies (Phase 4)Study completedNCT00202644What this trial is testingAnagrelide and Hydroxyurea in High-Risk Essential Thrombocythemia PatientsWho this might be right forThrombocythemia, Hemorrhagic Shire 150
Testing effectiveness (Phase 2)UnknownNCT04878003What this trial is testingStudy of KRT-232 or TL-895 in Janus Associated Kinase Inhibitor Treatment-Naïve MyelofibrosisWho this might be right forPrimary Myelofibrosis (PMF)Post-Polycythemia Vera Myelofibrosis (Post-PV-MF)Post-Essential Thrombocythemia Myelofibrosis (Post-ET-MF) Kartos Therapeutics, Inc. 52
Testing effectiveness (Phase 2)Study completedNCT00823524What this trial is testingDonor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced CancerWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more Asan Medical Center 47
Early research (Phase 1)Study completedNCT00042900What this trial is testingPyroxamide in Treating Patients With Advanced CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+5 more Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT05835466What this trial is testingReparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)Who this might be right forMyelofibrosis (PMF)Post Essential Thrombocythemia Myelofibrosis (ET-MF)Post Polycythemia Vera Related Myelofibrosis (PV-MF) Icahn School of Medicine at Mount Sinai 10
Large-scale testing (Phase 3)Study completedNCT00006083What this trial is testingDalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a CatheterWho this might be right forCervical CancerChronic Myeloproliferative DisordersLeukemia+6 more Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT01134120What this trial is testingA Study in Myeloproliferative DisordersWho this might be right forMyeloproliferative DisordersThrombocythemia, EssentialPolycythemia Vera+1 more Eli Lilly and Company 80
Testing effectiveness (Phase 2)Study completedNCT00005622What this trial is testingDonor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic DisordersWho this might be right forChronic Myeloproliferative DisordersLeukemiaMultiple Myeloma and Malignant Plasma Cell Neoplasms+2 more H. Lee Moffitt Cancer Center and Research Institute 72
Testing effectiveness (Phase 2)Study completedNCT01901432What this trial is testingA Two-part Study to Assess the Safety and Preliminary Efficacy of Givinostat in Patients With Polycythemia VeraWho this might be right forPolycythemia Vera Italfarmaco 48
Testing effectiveness (Phase 2)Looking for participantsNCT06770842What this trial is testingRopeginterferon Alfa 2b Plus Ruxolitinib for MyelofibrosisWho this might be right forPrimary Myelofibrosis (PMF)Post Polycythemia Myelofibrosis (PPV MF)Post Essential Thrombocythaemia Myelofibrosis (PET-MF) The University of Hong Kong 20
Testing effectiveness (Phase 2)Study completedNCT00006379What this trial is testingNon-Ablative Allo HSCT For Hematologic Malignancies or SAAWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+5 more Case Comprehensive Cancer Center 58
Not applicableWithdrawnNCT02663648What this trial is testingCell Cycle Regulatory Gene Study in Patients With Myeloproliferative DisordersWho this might be right forMyeloproliferative DisordersPolycythemia VeraEssential Thrombocythemia+2 more Shandong University
Not applicableStudy completedNCT01831635What this trial is testingMyeloproliferative Neoplasms: an In-depth Case-control StudyWho this might be right forPolycythemia VeraEssential ThrombocythemiaPrimary Myelofibrosis Queen's University, Belfast 234
Not applicableStudy completedNCT03907436What this trial is testingThe NUTRIENT Trial (NUTRitional Intervention Among myEloproliferative Neoplasms): Feasibility PhaseWho this might be right forMyeloproliferative DisorderMyeloproliferative SyndromeMyelofibrosis+2 more University of California, Irvine 30
Large-scale testing (Phase 3)UnknownNCT02611973What this trial is testingHydroxyurea Versus Aspirin and Hydroxyurea in Essential ThrombocythemiaWho this might be right forMPNEssential Thrombocythemia Assistance Publique - Hôpitaux de Paris 2,250
Early research (Phase 1)Study completedNCT00003451What this trial is testingInterleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more National Cancer Institute (NCI) 40
Not applicableUnknownNCT05921838What this trial is testingThe Role of Circ0014614 in the Formation and Development of ETWho this might be right forPrimary Thrombocytosis Nanfang Hospital, Southern Medical University 120
Large-scale testing (Phase 3)Study completedNCT01065038What this trial is testingAnagrelide vs. Hydroxyurea - Efficacy and Tolerability Study in Patients With Essential ThrombocythaemiaWho this might be right forEssential Thrombocythaemia AOP Orphan Pharmaceuticals AG
Large-scale testing (Phase 3)Looking for participantsNCT05198960What this trial is testingAVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative NeoplasmsWho this might be right forPolycythemia VeraEssential ThrombocythemiaPrefibrotic/Early Primary Myelofibrosis+2 more University Hospital, Brest 1,308